JP2022514401A5 - - Google Patents

Info

Publication number
JP2022514401A5
JP2022514401A5 JP2021535715A JP2021535715A JP2022514401A5 JP 2022514401 A5 JP2022514401 A5 JP 2022514401A5 JP 2021535715 A JP2021535715 A JP 2021535715A JP 2021535715 A JP2021535715 A JP 2021535715A JP 2022514401 A5 JP2022514401 A5 JP 2022514401A5
Authority
JP
Japan
Prior art keywords
compound
general formula
dihydroxy
acid
difluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021535715A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022514401A (ja
JP7503063B2 (ja
Filing date
Publication date
Priority claimed from GBGB1820887.6A external-priority patent/GB201820887D0/en
Application filed filed Critical
Publication of JP2022514401A publication Critical patent/JP2022514401A/ja
Publication of JP2022514401A5 publication Critical patent/JP2022514401A5/ja
Application granted granted Critical
Publication of JP7503063B2 publication Critical patent/JP7503063B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021535715A 2018-12-20 2019-12-20 神経変性疾患の治療のための2-フッ素化胆汁酸 Active JP7503063B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1820887.6 2018-12-20
GBGB1820887.6A GB201820887D0 (en) 2018-12-20 2018-12-20 Compounds
PCT/GB2019/053665 WO2020128514A1 (en) 2018-12-20 2019-12-20 2-fluorinated bile acids for the treatment of neurodegenerative diseases

Publications (3)

Publication Number Publication Date
JP2022514401A JP2022514401A (ja) 2022-02-10
JP2022514401A5 true JP2022514401A5 (https=) 2022-12-13
JP7503063B2 JP7503063B2 (ja) 2024-06-19

Family

ID=65364420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021535715A Active JP7503063B2 (ja) 2018-12-20 2019-12-20 神経変性疾患の治療のための2-フッ素化胆汁酸

Country Status (15)

Country Link
US (1) US20220073557A1 (https=)
EP (1) EP3898645B1 (https=)
JP (1) JP7503063B2 (https=)
KR (1) KR102856276B1 (https=)
CN (1) CN113330020B (https=)
AU (1) AU2019411556B2 (https=)
BR (1) BR112021011189A2 (https=)
CA (1) CA3123333A1 (https=)
EA (1) EA202191521A1 (https=)
ES (1) ES3036094T3 (https=)
GB (1) GB201820887D0 (https=)
IL (1) IL284093B2 (https=)
MX (1) MX2021007551A (https=)
SG (1) SG11202105465WA (https=)
WO (1) WO2020128514A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4486318A4 (en) * 2022-03-02 2026-02-25 Boyce Thompson Institute For Plant Res Inc Cysteamides, related therapeutic compositions and associated processes
GB202208151D0 (en) 2022-06-01 2022-07-13 Nzp Uk Ltd Compounds
GB202314563D0 (en) 2023-09-22 2023-11-08 Nzp Uk Ltd Compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ298567A (en) * 1994-11-23 2000-01-28 Cocensys Inc Androstane and pregnane derivatives, pharmaceutical compositions and methods of treatment
WO1998005337A1 (en) * 1996-08-01 1998-02-12 Cocensys, Inc. Use of gaba and nmda receptor ligands for the treatment of migraine headache
FR2934596B1 (fr) * 2008-07-30 2015-04-10 Trophos Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
ITMI20121344A1 (it) * 2012-07-31 2014-02-01 Erregierre Spa Processo di preparazione di acido ursodesossicolico ad elevata purezza
WO2014036377A1 (en) 2012-08-31 2014-03-06 Metselex Methods of promoting cell viability
CN103333216A (zh) * 2013-06-04 2013-10-02 苏州大学 5α-6-酮-胆甾烷类似物及其应用
US20150112089A1 (en) 2013-10-22 2015-04-23 Metselex, Inc. Deuterated bile acids
US11072630B2 (en) * 2015-03-10 2021-07-27 Metselex, Inc. Fluorinated and alkylated bile acids
GB201812382D0 (en) * 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds

Similar Documents

Publication Publication Date Title
CA2361716C (en) Method of preparing alkylated salicylamides
TWI290132B (en) Novel compounds and compositions as protease inhibitors
US8106192B2 (en) Method for producing 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
JP2022514401A5 (https=)
US6833453B2 (en) Methods of producing oxazolidinone compounds
RU2004112780A (ru) Производные и промежуточные соединения n-адамантилметила в качестве фармацевтических композиций и способы их получения
JP2005514373A5 (https=)
JPS61500549A (ja) 非イオン性放射線写真コントラスト媒体のための新合成方法
JPH0363541B2 (https=)
JP4393376B2 (ja) フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用
ZA200210161B (en) Coumarin derivatives with COMT inhibiting activity.
JP2003506432A (ja) カルボン酸アミド、その調製法及び医薬組成物としてのその使用
EP0349902A2 (en) Processes for the preparation of morniflumate and analogous compounds
RU2008128566A (ru) Органические соединения
DE3111025C2 (https=)
JP2005510559A5 (https=)
US6211384B1 (en) Methods for the acylation of amine compounds
KR100220876B1 (ko) 항 바이러스 화합물
CN113660932B (zh) 具有侧链烷基与烯基延伸的苯基衍生物及包括有其的药学组合物
JPH02235873A (ja) オキサゾリジンジオン誘導体及びその製法
ES2343808T3 (es) Derivados de formamida utiles como adrenoceptores.
KR810000357B1 (ko) 치환 벤즈아미드류의 제법
JPS62255462A (ja) N−(3′,4′−ジメトキシシンナモイル)アントラニル酸の製造方法
FR2843750A1 (fr) Composes derives d'arylcarbamates, preparation et utilisations
EP2489655A1 (en) Process for preparation of diethylenetriaminepentaacetic acid derivatives, and diethylenetriaminepentaacetic acid derivatives